フォロー
Ana Lopez-Machado
Ana Lopez-Machado
確認したメール アドレス: ub.edu
タイトル
引用先
引用先
Metal-based nanoparticles as antimicrobial agents: an overview
E Sánchez-López, D Gomes, G Esteruelas, L Bonilla, AL Lopez-Machado, ...
Nanomaterials 10 (2), 292, 2020
12122020
Current applications of nanoemulsions in cancer therapeutics
E Sánchez-López, M Guerra, J Dias-Ferreira, A Lopez-Machado, ...
Nanomaterials 9 (6), 821, 2019
2202019
Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome—Review of classical and new compounds: Part-I
R Vieira, SB Souto, E Sánchez-López, A López Machado, P Severino, ...
Pharmaceuticals 12 (4), 152, 2019
1932019
Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents
EB Souto, J Dias-Ferreira, A López-Machado, M Ettcheto, A Cano, ...
Pharmaceutics 11 (9), 460, 2019
1812019
Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases
A Cano, E Sánchez-López, M Ettcheto, A Lopez-Machado, M Espina, ...
Nanomedicine 15 (12), 1239-1261, 2020
1132020
Trends in atopic dermatitis—from standard pharmacotherapy to novel drug delivery systems
EB Souto, J Dias-Ferreira, J Oliveira, E Sanchez-Lopez, ...
International journal of molecular sciences 20 (22), 5659, 2019
752019
State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections
A Cano, M Ettcheto, M Espina, A López-Machado, Y Cajal, F Rabanal, ...
Journal of nanobiotechnology 18, 1-24, 2020
722020
Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome—strategies for in vivo administration: part-II
R Vieira, SB Souto, E Sánchez-López, A López Machado, P Severino, ...
Journal of clinical medicine 8 (9), 1332, 2019
682019
Development of lactoferrin-loaded liposomes for the management of dry eye disease and ocular inflammation
A López-Machado, N Díaz-Garrido, A Cano, M Espina, J Badia, ...
Pharmaceutics 13 (10), 1698, 2021
612021
Development of topical eye-drops of lactoferrin-loaded biodegradable nanoparticles for the treatment of anterior segment inflammatory processes
A López-Machado, N Díaz, A Cano, M Espina, J Badía, L Baldomà, ...
International journal of pharmaceutics 609, 121188, 2021
342021
Lipid nanoparticles as carriers for the treatment of neurodegeneration associated with Alzheimer’s disease and glaucoma: Present and future challenges
ES López, ALL Machado, LB Vidal, R González-Pizarro, AD Silva, ...
Current Pharmaceutical Design 26 (12), 1235-1250, 2020
182020
Colloidal hydrogel systems of thymol-loaded PLGA nanoparticles designed for acne treatment
C Folle, AM Marqués, M Mallandrich, J Suñer-Carbó, L Halbaut, ...
Colloids and Surfaces B: Biointerfaces 234, 113678, 2024
72024
In vitro immunomodulatory capacity of Lactoferrin liposomes
LB Vidal, ES López, M Biancardi, AR Blanco, G Esteruelas, ...
Investigative Ophthalmology & Visual Science 65 (7), 3602-3602, 2024
12024
Lactoferrin liposomal eyedrops: physicochemical characterization, cytotoxicity and ocular tolerance
ES López, LB Vidal, G Esteruelas, M Biancardi, AR Blanco, ...
Investigative Ophthalmology & Visual Science 65 (7), 3604-3604, 2024
2024
Desarrollo de sistemas nanoestructurados conteniendo Lactoferrina para el tratamiento de patologías oculares
AL López Machado
Universitat de Barcelona, 2022
2022
Nanopartícules polimèriques d'epigalocatequina-3-galat, un enfocament nanotecnològic per tractar la malaltia d'Alzheimer
A Cano Fernández, M Ettcheto Arriola, M Espina García, ...
Circular Farmacèutica, 2019, vol. 77, num. 1, p. 5-7, 2019
2019
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–16